Health Status of Young Adults with Insurance Coverage Before and After Affordable Care Act Passage.


Journal

The Permanente journal
ISSN: 1552-5775
Titre abrégé: Perm J
Pays: United States
ID NLM: 9800474

Informations de publication

Date de publication:
2019
Historique:
entrez: 3 4 2019
pubmed: 3 4 2019
medline: 5 9 2019
Statut: ppublish

Résumé

The purpose of this study was to assess changes in health status of California young adults with insurance coverage before and after passage of the Affordable Care Act (ACA). For this cross-sectional descriptive study, electronic health record information for young adults between ages 18 and 25 years enrolled in a large Southern California Health Plan in 2008, 2010, or 2015 was obtained (N = 665,686). Absolute changes and standardized annual differences in demographics and age-sex-race standardized prevalence of Elixhauser health conditions for pre-ACA (2008-2010) and post-ACA (2010-2015) periods were calculated. The number of young adults enrolled in the Health Plan increased by 145,000 (65%) during the ACA transition with a shift toward low-income young adults. The increase in high-deductible insurance plans observed pre-ACA stabilized with a standardized annual difference of 0.22 pre-ACA vs 0.05 post-ACA. The prevalences of obesity and other health conditions between pre-ACA and post-ACA periods essentially were unaltered and comparable between young adults who became new members (< 1 year) and those with long-term memberships (≥ 3 years). In this California health care system, the health status of new young adult members was comparable to that of long-term members. Future research should assess whether these young adults retain their health insurance coverage after turning age 26 years and being removed from their parents' insurance plans.

Identifiants

pubmed: 30939274
pii: 17-223
doi: 10.7812/TPP/17-223
pmc: PMC6443370
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
JAMA. 2002 May 15;287(19):2519-27
pubmed: 12020332
Ann Epidemiol. 2004 May;14(5):339-45
pubmed: 15177273
Public Health. 2007 Jul;121(7):492-6
pubmed: 17399752
Soc Sci Med. 2007 Dec;65(12):2458-63
pubmed: 17761378
Diabetes Care. 2008 May;31(5):899-904
pubmed: 18223030
Med Care. 2009 Jun;47(6):626-33
pubmed: 19433995
Diabetes Care. 2010 Mar;33(3):569-76
pubmed: 20040657
J Am Acad Dermatol. 2011 Nov;65(5):957-64
pubmed: 21306784
JAMA. 2012 Mar 7;307(9):913-4
pubmed: 22396509
Ann Epidemiol. 2012 Sep;22(9):609-16
pubmed: 22766471
Popul Health Metr. 2012 Aug 21;10(1):15
pubmed: 22909293
Health Serv Res. 2012 Oct;47(5):1773-90
pubmed: 22924684
Perm J. 2012 Summer;16(3):37-41
pubmed: 23012597
Med Care Res Rev. 2013 Jun;70(3):330-45
pubmed: 23169896
Health Aff (Millwood). 2013 Jan;32(1):165-74
pubmed: 23255048
N Engl J Med. 2013 May 30;368(22):2105-12
pubmed: 23718165
J Adolesc Health. 2014 Jun;54(6):663-71
pubmed: 24702839
Transl Behav Med. 2014 Jun;4(2):170-4
pubmed: 24904700
Perm J. 2015 Summer;19(3):4-10
pubmed: 26057681
Med Care. 2016 May;54(5):519-27
pubmed: 26918403
NCHS Data Brief. 2016 Mar;(239):1-8
pubmed: 27019018
Health Informatics J. 2017 Dec;23(4):260-267
pubmed: 27161140
NCHS Data Brief. 2016 Oct;(262):1-8
pubmed: 27805549
Health Aff (Millwood). 2016 Dec 1;35(12):2297-2301
pubmed: 27920319
Diabetes Care. 2017 Feb;40(2):239-245
pubmed: 27956384

Auteurs

Gelliza B Gervacio (GB)

Department of Research and Evaluation, Kaiser Permanente, Pasadena, CA.
Precision for Medicine Oncology and Rare Disease, Carlsbad, CA.

Margo Sidell (M)

Department of Research and Evaluation, Kaiser Permanente, Pasadena, CA.

Xia Li (X)

Department of Research and Evaluation, Kaiser Permanente, Pasadena, CA.

Deborah R Young (DR)

Department of Research and Evaluation, Kaiser Permanente, Pasadena, CA.

Michael Batech (M)

Merck KGaA, Darmstadt, Germany.

Lei Qian (L)

Department of Research and Evaluation, Kaiser Permanente, Pasadena, CA.

Kristi Reynolds (K)

Department of Research and Evaluation, Kaiser Permanente, Pasadena, CA.

Corinna Koebnick (C)

Department of Research and Evaluation, Kaiser Permanente, Pasadena, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH